Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Clascoterone vs Mandelic Acid (topical): Clascoterone has the stronger overall evidence (7 vs 5/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Clascoterone wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Clascoterone and Mandelic Acid (topical) have evidence — compare verdict strength side-by-side.
Apply a thin layer of clascoterone 1% cream to the affected area twice daily, morning and evening, on clean dry skin
Morning and evening
Clascoterone 1% cream
Topical cosmetic only. Leave-on mandelic acid is used at roughly 5-10% in serums; professional peels use higher strengths (often a salicylic-mandelic combination). Apply to clean skin, building frequency as tolerated, with daily sunscreen. There is no oral or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
evening
Leave-on serum (≈5-10% mandelic acid) or a professional (salicylic-)mandelic peel
immediate
12 weeks
12 weeks
1-4 weeks
Throughout
8-12 weeks
8-12 weeks
Throughout
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
JAMA Dermatol (2020) · Rct · n=1440
The pivotal registration trials: two identical phase 3 studies, 1440 patients randomised, conducted November 2015 to April 2018.
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris
J Drugs Dermatol (2023) · Rct · n=1421
709 patients received clascoterone and 712 received vehicle in the pooled ≥12-year population.
Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials
Dermatol Ther (2021) · Meta analysis · n=2457
Five trials, 2457 patients (1357 clascoterone, 1100 placebo), overall low risk of bias.
Comparative study of efficacy and safety of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris.
J Cosmet Dermatol (2020) · Rct · n=50
RCT (n=50): 45% mandelic acid vs 30% salicylic acid peels every 2 weeks for six sessions over 12 weeks
Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
Dermatol Surg (2016) · Rct · n=90
RCT (n=90): glycolic 35% vs salicylic-mandelic vs phytic acid peels for melasma over 12 weeks
Comparative Study of 35% Glycolic Acid, 20% Salicylic-10% Mandelic Acid, and Phytic Acid Combination Peels in the Treatment of Active Acne and Postacne Pigmentation.
J Cutan Aesthet Surg (2019) · Rct · n=45
RCT (n=45): glycolic vs salicylic-mandelic vs phytic peels biweekly for six sessions
Clascoterone has a higher evidence score (7/10 vs 5/10) and wins in 2 of 3 categories.
For clearer skin (acne), Clascoterone has a higher relevance score (92 vs 60).
No known interactions between Clascoterone and Mandelic Acid (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.